Related Experiment Video
Updated: Jul 28, 2026

Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer
Published on: June 13, 2019
SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein
C Geng1,2, S Kaochar1,2, M Li1,2
1Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Abstract:
The E3 ubiquitin ligase adaptor speckle-type POZ protein (SPOP) is frequently dysregulated in prostate adenocarcinoma (PC), via either somatic mutations or mRNA downregulation, suggesting an important tumour suppressor function. To examine its physiologic role in the prostate epithelium in vivo, we generated mice with prostate-specific biallelic ablation of Spop. These mice exhibited increased prostate mass, prostate epithelial cell proliferation, and expression of c-MYC protein compared to littermate controls, and eventually developed prostatic intraepithelial neoplasia (PIN). We found that SPOPWT can physically interact with c-MYC protein and, upon exogenous expression in vitro, can promote c-MYC ubiquitination and degradation. This effect was attenuated in PC cells by introducing PC-associated SPOP mutants or upon knockdown of SPOP via short-hairpin-RNA, suggesting that SPOP inactivation directly increases c-MYC protein levels. Gene Set Enrichment Analysis revealed enrichment of Myc-induced genes in transcriptomic signatures associated with SPOPMT. Likewise, we observed strong inverse correlation between c-MYC activity and SPOP mRNA levels in two independent PC patient cohorts. The core SPOPMT;MYCHigh transcriptomic response, defined by the overlap between the SPOPMT and c-MYC transcriptomic programmes, was also associated with inferior clinical outcome in human PCs. Finally, the organoid-forming capacity of Spop-null murine prostate cells was more sensitive to c-MYC inhibition than that of Spop-WT cells, suggesting that c-MYC upregulation functionally contributes to the proliferative phenotype of Spop knock-out prostates. Taken together, our data highlight SPOP as an important regulator of luminal epithelial cell proliferation and c-MYC expression in prostate physiology, identify c-MYC as a novel bona fide SPOP substrate, and help explain the frequent inactivation of SPOP in human PC. We propose SPOPMT-induced stabilization of c-MYC protein as a novel mechanism that can increase total c-MYC levels in PC cells, in addition to amplification of c-MYC locus.
Insights
Speckle-type POZ protein (SPOP) loss in prostate cancer promotes cell proliferation by stabilizing c-MYC. This study identifies c-MYC as a direct SPOP substrate, explaining SPOP
Area of Science:
- Oncology
- Molecular Biology
- Urology
Background:
- Speckle-type POZ protein (SPOP) is frequently dysregulated in prostate adenocarcinoma (PC), suggesting a tumor suppressor role.
- SPOP inactivation, through mutations or reduced mRNA, is linked to PC development.
Purpose of the Study:
- To investigate the physiological role of SPOP in prostate epithelium in vivo.
- To determine the molecular mechanism linking SPOP dysregulation to prostate cancer progression.
Main Methods:
- Generated prostate-specific SPOP-ablated mice.
- Assessed prostate mass, cell proliferation, and c-MYC expression.
- Performed in vitro SPOP-c-MYC interaction and ubiquitination assays.
- Analyzed transcriptomic data and patient cohorts for SPOP and c-MYC correlations.
- Utilized organoid models for functional studies.
Main Results:
- SPOP ablation in mice led to increased prostate mass, proliferation, and c-MYC levels, eventually causing prostatic intraepithelial neoplasia (PIN).
- SPOP directly ubiquitinates and degrades c-MYC; this is impaired by PC-associated SPOP mutants.
- Transcriptomic analysis revealed enrichment of c-MYC-driven genes in SPOP-mutated contexts, correlating with poor clinical outcomes in PC patients.
- Spop-null prostate cells were more sensitive to c-MYC inhibition, confirming c-MYC's role in proliferation.
Conclusions:
- SPOP is a key regulator of prostate luminal epithelial cell proliferation and c-MYC expression.
- c-MYC is identified as a novel substrate of SPOP, and its stabilization upon SPOP inactivation is a mechanism contributing to PC.
- SPOP dysregulation and subsequent c-MYC stabilization represent a significant pathway in prostate adenocarcinoma pathogenesis.
Related Concept Videos
Negative Regulator Molecules
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Epigenetic Regulation
X-chromosome...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Induced Pluripotent Stem Cells
Somatic cells are...

